title: [Surgical treatment of children with hepatic tumours].
abstract: BACKGROUND
  In this paper we review the results of surgical treatment of children with hepatic tumours.
  
  
  METHODS
  The study comprises 33 children who have undergone lever resection or liver transplantation since 1990. 26 patients had hepatoblastoma, 3 had hepatocellular carcinoma, 2 had rhabdomyosarcoma, 1 had a mesenchymal tumour, and 1 had a giant haemangioma.
  
  
  RESULTS
  Because of the number of patients, we only analyzed the results of the treatment in the hepatoblastoma group. The survival was the same after resection (77.3%) and liver transplantation (75%). There was no difference in survival dependent on the type of resection, and there was no impact of the extension of tumour growth at the time of diagnosis.
  
  
  CONCLUSIONS
  The combination of neoadjuvant chemotherapy followed by liver resection or liver transplantation is the treatment of choice in all children with hepatoblastoma. The results have improved dramatically over the last decades. The results in Denmark compare well with international results. Since 2000, very effective chemotherapy has downstaged all referred patients, so subsequent liver resection have been possible.
authors.affiliation: Rigshospitalet, Abdominalcentret, Kirurgisk Gastroenterologisk Klinik C, København Ø. allan.rasmussen@dadlnet.dk
authors.forename: Allan
authors.initials: A
authors.lastname: Rasmussen
authors.forename: Nina
authors.initials: N
authors.lastname: Kvist
authors.forename: Preben
authors.initials: P
authors.lastname: Kirkegaard
authors.forename: Cathrine
authors.initials: C
authors.lastname: Rechnitzer
mesh_terms: D002648:Child; D006498:Hepatectomy; D018197:Hepatoblastoma / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000601:surgery*; D016031:Liver Transplantation; D020360:Neoadjuvant Therapy; D016019:Survival Analysis; D016896:Treatment Outcome